
结论很明确:这个市场不适合普通新品牌现在进入,已经是明显拥挤、价格竞争加剧的赛道;但对少数具备差异化能力的大品牌来说,仍有条件性机会。你的50万人民币预算,够做单个ASIN试水,但不够安全复制已经跑通的高投入模型。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不适合进入,至少以你现在的预算和常规打法不建议做。 你有 50万人民币,理论上能覆盖少数低门槛新品的前期入场,但市场里真正跑出来的新品,已经明显被旧品牌和高投入品牌占住;同时,新品牌新品盈利率只有 45.45%,新品牌新品亏损率也有 36.36%,说明不是“进场就能赚”,而是强筛选市场。
预算层面,你够做“单个 ASIN 的前期试水”,但不够做安全扩张。 低门槛成功样本里,iEarve 的单品预算约 4,892.12 元,售价 36.05 美元,利润率 35.5%,月销约 200、月营收约 72.1 万;但这类样本非常少。另一边,VOLUETH 的成功单品预算约 125,705.51 元,售价 49.99 美元,利润率 36.78%,而它的失败款直接没有跑起来。更关键的是,像 Oklar 这种老品牌,B0CHXY8WQW 预算约 35,578.48 元、利润率 38.5%、月销约 4 万、月营收约 1.1304 亿;B0CCXHL3JJ 预算接近同级,利润率 31.89%、月销约 3 万、月营收约 6,579 万。也就是说,能赚的不是便宜货,而是品牌势能、稳定流量和持续投放,这不是 50万预算能稳妥复制的。
更致命的是,市场已经呈现强烈同质化和价格竞争信号。 典型通用款如 B0GYNRQF3L,卖 $12.44,利润率只有 5.23%,说明低价段基本是价格战区;而市场里高利润产品多数来自旧品牌或重投入品牌,不是普通小卖家可复制的自然成功。唯一可以当小卖家参考的真实案例是 iEarve 的 B0FYPXYWD5;大预算如果硬要做,只能盯着 Oklar 的 B0CHXY8WQW、B0CCXHL3JJ,或者模仿 VOLUETH 的 B0H3P74MT9 这种高投入新品,但这意味着你要准备接近 12.6 万元级别的单 ASIN 入场成本,还要额外承担研发、品牌和认证成本。短结论:不建议小卖家进入;大品牌也只有在重投入、强品牌、强差异化条件下才勉强可做。
Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,结论很明确:已经进入价格战区域,且对新品牌不友好。 目前可见样本里,整体可盈利比例只有53.01%,但新上架产品的可盈利比例只有41.86%;更关键的是,低价同质化产品已经把利润压到很窄,像 WellWink 的 B0GYNRQF3L 只有5.23%利润率,JALIP 的 B0H38WFTCD 直接亏损,说明新进者要么没差异化,要么利润根本撑不住推广和退货。
结论很明确:这个市场不适合新品牌现在进入,尤其不适合小品牌;它已经进入明显的价格战+品牌分化阶段。 但如果你是旧品牌扩品,且能承受更高投放和产品差异化成本,仍有机会做出少数高利润款。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0CHXY8WQW | Oklar | 2023-09-13 | Yes | $28.26 | 40000pcs | $1130400.0 | 38.5% | $435204.0 |
![]() | B0CCXHL3JJ | Oklar | 2023-07-27 | Yes | $21.93 | 30000pcs | $657900.0 | 31.89% | $209804.31 |
![]() | B08DP2KZ9X | yuwell | 2020-10-13 | Yes | $28.37 | 3000pcs | $85110.0 | 30.0% | $25533.0 |
![]() | B0FG79LB6M | sinocare | 2025-07-01 | Yes | $17.58 | 7000pcs | $123060.0 | 18.81% | $23147.59 |
![]() | B0DNPJQK9Z | maguja | 2024-11-21 | Yes | $18.24 | 4000pcs | $72960.0 | 21.25% | $15504.0 |
![]() | B0BF9YHRFM | AILE | 2022-09-14 | Yes | $23.08 | 2000pcs | $46160.0 | 28.07% | $12957.12 |
![]() | B00IWRRS6C | A&D Medical | 2014-03-19 | Yes | $30.61 | 1000pcs | $30610.0 | 33.47% | $10245.17 |
![]() | B0DB5PR5J5 | GUAEVER | 2024-07-25 | Yes | $29.48 | 1000pcs | $29480.0 | 31.81% | $9377.59 |
![]() | B0F87SW1SJ | KIKEANG | 2025-10-04 | Yes | $33.73 | 800pcs | $26984.0 | 34.72% | $9368.85 |
![]() | B08Y5TLD3C | MBUPAI | 2021-02-04 | Yes | $20.3 | 1000pcs | $20300.0 | 28.15% | $5714.45 |
![]() | B0DLW2KKVL | DOUHAO | 2023-05-06 | Yes | $19.68 | 1000pcs | $19680.0 | 25.99% | $5114.84 |
![]() | B0FMNNTV82 | Coverich | 2026-01-21 | Yes | $19.44 | 1000pcs | $19440.0 | 26.18% | $5089.4 |
![]() | B0DM1XS674 | NOUYAN | 2024-11-05 | Yes | $20.72 | 1000pcs | $20720.0 | 23.91% | $4954.16 |
![]() | B0D86YMNS9 | BESTEK | 2024-06-27 | Yes | $21.55 | 800pcs | $17240.0 | 25.43% | $4384.14 |
![]() | B0FMNP1TFD | Coverich | 2025-08-16 | Yes | $17.59 | 1000pcs | $17590.0 | 23.7% | $4168.83 |
![]() | B0G6DZ4WQ3 | BENECEN | 2025-12-25 | Yes | $17.9 | 800pcs | $14320.0 | 24.11% | $3452.56 |
![]() | B0FMWQMG6X | Oklar | 2025-08-19 | Yes | $22.06 | 500pcs | $11030.0 | 28.33% | $3124.8 |
![]() | B0021ZJVKM | Omron | 2012-08-07 | Yes | $18.92 | 500pcs | $9460.0 | 30.36% | $2872.06 |
![]() | B0H3P74MT9 | VOLUETH | 2026-06-02 | Yes | $49.99 | 150pcs | $7498.5 | 36.78% | $2757.95 |
![]() | B0BGBJGFM5 | rihaory | 2022-09-25 | Yes | $14.04 | 1000pcs | $14040.0 | 19.63% | $2756.06 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0F87SW1SJ | KIKEANG | 2025-10-04 | Yes | $33.73 | 800pcs | $26984.0 | 34.72% | $9368.85 |
![]() | B0FMNNTV82 | Coverich | 2026-01-21 | Yes | $19.44 | 1000pcs | $19440.0 | 26.18% | $5089.4 |
![]() | B0FMNP1TFD | Coverich | 2025-08-16 | Yes | $17.59 | 1000pcs | $17590.0 | 23.7% | $4168.83 |
![]() | B0G6DZ4WQ3 | BENECEN | 2025-12-25 | Yes | $17.9 | 800pcs | $14320.0 | 24.11% | $3452.56 |
![]() | B0FMWQMG6X | Oklar | 2025-08-19 | Yes | $22.06 | 500pcs | $11030.0 | 28.33% | $3124.8 |
![]() | B0H3P74MT9 | VOLUETH | 2026-06-02 | Yes | $49.99 | 150pcs | $7498.5 | 36.78% | $2757.95 |
![]() | B0GSZW3W62 | Wishlove | 2026-03-18 | Yes | $18.25 | 600pcs | $10950.0 | 24.03% | $2631.29 |
![]() | B0FYPXYWD5 | iEarve | 2026-03-18 | Yes | $36.05 | 200pcs | $7210.0 | 35.5% | $2559.55 |
![]() | B0G6F2V8X1 | BENECEN | 2025-12-25 | Yes | $18.04 | 300pcs | $5412.0 | 24.33% | $1316.74 |
![]() | B0F5W25YNX | GUAEVER | 2025-09-20 | Yes | $29.47 | 100pcs | $2947.0 | 34.53% | $1017.6 |
![]() | B0FXMDGDH2 | HealthTree | 2025-10-24 | Yes | $20.7 | 100pcs | $2070.0 | 27.29% | $564.91 |
![]() | B0FWCNZW2H | Alcarefam | 2025-10-15 | Yes | $12.07 | 200pcs | $2414.0 | 14.63% | $353.17 |
![]() | B0F4RF2PYW | Checkme | 2026-06-22 | Yes | $15.99 | 100pcs | $1599.0 | 20.49% | $327.64 |
![]() | B0FP9QF95C | Oklar | 2025-08-30 | Yes | $21.96 | 50pcs | $1098.0 | 28.1% | $308.54 |
![]() | B0FM7VS9K7 | Oklar | 2025-08-15 | Yes | $21.29 | 50pcs | $1064.5 | 27.49% | $292.64 |
![]() | B0DRGDXL4C | Checkme | 2026-06-22 | Yes | $17.08 | 50pcs | $854.0 | 23.81% | $203.34 |
![]() | B0G7W56JF8 | BENECEN | 2025-12-17 | Yes | $19.84 | 50pcs | $992.0 | 19.57% | $194.14 |
![]() | B0GVXQGBPJ | sinocare | 2026-04-03 | Yes | $19.45 | 50pcs | $972.5 | 19.04% | $185.17 |
这个市场不值得进入,属于高竞争、明显价格战风险的赛道。新产品整体可见成功率只有41.86%,但真正可识别利润的总体产品也只有53.01%,而且今年新增产品里失败已经很集中:2026年可见新上新中,盈利7个、亏损12个,新增节奏还在加快,说明竞争并没有变轻,反而在继续加码。
大品牌进入门槛高,但不是“靠砸钱就能赢”的开放市场。像 Oklar、Checkme、GUAEVER、sinocare 这类老品牌仍在拿到成功产品,说明老玩家有明显品牌势能;其中 GUAEVER 的成功款 B0F5W25YNX 月收入约2947美元,投入预算高达116074.56美元,说明大品牌想切入要准备更重的品牌和推广投入。反过来看,小品牌里真正能成立的案例主要是“功能差异化+低价”路线:KIKEANG 的 B0F87SW1SJ 预算约25583.07美元,月收入约26984美元,卖点是儿童/成人双袖带;Coverich 的 B0FMNNTV82 月收入约19440美元,B0FMNP1TFD 月收入约17590美元,核心也是便携、语音、大字屏这类明确痛点。与之相对,WellWink 的 B0GYNRQF3L 虽然月收入高达49760美元,但因为卖点同质化而亏损,说明这不是靠跑量就能活的市场。
结论很直接:小品牌可以“有条件地”成功,但只能走强差异化,不是普通白牌机会;市场也没有超大规模品牌涌入到30+新品牌那种极端过热,但已经进入明显拥挤区。BENECEN 作为新入场品牌,4个产品里3个盈利,成功率75%,但它的打法本质上是围绕腕式、记忆数、便携等细分痛点做组合;这类成功不算低门槛通用款。对你来说,单个ASIN预算只有500000 CNY,足够覆盖多数样品预算,但如果要做出像 B0F87SW1SJ、B0FMNNTV82 这种成功款,仍要额外预留品牌、认证和持续投放成本。不建议贸然进入;若一定要做,只能选“儿童/大臂围/便携/多袖带兼容”这类强差异化细分,并且要接受前期投放和产品设计投入偏重。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场已经进入过热区,不适合现在新进。 近期开新品牌不算少,但盈利能力在走弱:整体可识别利润产品只有53.01%,新品盈利率更低只有41.86%;更关键的是,2026年新品里盈利/亏损/未明朗几乎各占一半,说明竞争正在加剧,后进者越来越难做。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 2 | 7 | 2 | 0 | 6 |
| 2026 | 0 | 0 | 1 | 1 | 4 | 2 | 0 | 18 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025/10 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 3 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| 2026/1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| 2026/4 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 4 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |